IBDEI02X ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,910,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,910,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,910,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,911,0)
 ;;=R04.0^^6^102^7
 ;;^UTILITY(U,$J,358.3,911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,911,1,3,0)
 ;;=3^Epistaxis
 ;;^UTILITY(U,$J,358.3,911,1,4,0)
 ;;=4^R04.0
 ;;^UTILITY(U,$J,358.3,911,2)
 ;;=^5019173
 ;;^UTILITY(U,$J,358.3,912,0)
 ;;=G40.909^^6^102^6
 ;;^UTILITY(U,$J,358.3,912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,912,1,3,0)
 ;;=3^Epilepsy Not Intractable w/o Status Epilepticus
 ;;^UTILITY(U,$J,358.3,912,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,912,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,913,0)
 ;;=M77.9^^6^102^5
 ;;^UTILITY(U,$J,358.3,913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,913,1,3,0)
 ;;=3^Enthesopathy,Unspec
 ;;^UTILITY(U,$J,358.3,913,1,4,0)
 ;;=4^M77.9
 ;;^UTILITY(U,$J,358.3,913,2)
 ;;=^5013319
 ;;^UTILITY(U,$J,358.3,914,0)
 ;;=M10.9^^6^103^8
 ;;^UTILITY(U,$J,358.3,914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,914,1,3,0)
 ;;=3^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,914,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,914,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,915,0)
 ;;=H40.9^^6^103^7
 ;;^UTILITY(U,$J,358.3,915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,915,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,915,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,915,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,916,0)
 ;;=K21.9^^6^103^1
 ;;^UTILITY(U,$J,358.3,916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,916,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,916,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,916,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,917,0)
 ;;=K29.70^^6^103^4
 ;;^UTILITY(U,$J,358.3,917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,917,1,3,0)
 ;;=3^Gastritis w/o Bleeding,Unspec
 ;;^UTILITY(U,$J,358.3,917,1,4,0)
 ;;=4^K29.70
 ;;^UTILITY(U,$J,358.3,917,2)
 ;;=^5008552
 ;;^UTILITY(U,$J,358.3,918,0)
 ;;=K52.9^^6^103^5
 ;;^UTILITY(U,$J,358.3,918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,918,1,3,0)
 ;;=3^Gastroenteritis & Colitis Noninfective,Unspec
 ;;^UTILITY(U,$J,358.3,918,1,4,0)
 ;;=4^K52.9
 ;;^UTILITY(U,$J,358.3,918,2)
 ;;=^5008704
 ;;^UTILITY(U,$J,358.3,919,0)
 ;;=K82.9^^6^103^2
 ;;^UTILITY(U,$J,358.3,919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,919,1,3,0)
 ;;=3^Gallbladder Disease,Unspec
 ;;^UTILITY(U,$J,358.3,919,1,4,0)
 ;;=4^K82.9
 ;;^UTILITY(U,$J,358.3,919,2)
 ;;=^5008875
 ;;^UTILITY(U,$J,358.3,920,0)
 ;;=K92.2^^6^103^6
 ;;^UTILITY(U,$J,358.3,920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,920,1,3,0)
 ;;=3^Gastrointestinal Hemorrhage,Unspec
 ;;^UTILITY(U,$J,358.3,920,1,4,0)
 ;;=4^K92.2
 ;;^UTILITY(U,$J,358.3,920,2)
 ;;=^5008915
 ;;^UTILITY(U,$J,358.3,921,0)
 ;;=K25.9^^6^103^3
 ;;^UTILITY(U,$J,358.3,921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,921,1,3,0)
 ;;=3^Gastric Ulcer w/o Hemorrhage/Perforation
 ;;^UTILITY(U,$J,358.3,921,1,4,0)
 ;;=4^K25.9
 ;;^UTILITY(U,$J,358.3,921,2)
 ;;=^5008522
 ;;^UTILITY(U,$J,358.3,922,0)
 ;;=I69.959^^6^104^11
 ;;^UTILITY(U,$J,358.3,922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,922,1,3,0)
 ;;=3^Hemiplegia/Hemiparesis Following Unspec Cerebrovascular Disease
 ;;^UTILITY(U,$J,358.3,922,1,4,0)
 ;;=4^I69.959
 ;;^UTILITY(U,$J,358.3,922,2)
 ;;=^5007563
 ;;^UTILITY(U,$J,358.3,923,0)
 ;;=D89.2^^6^104^22
 ;;^UTILITY(U,$J,358.3,923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,923,1,3,0)
 ;;=3^Hypergammaglobulinemia,Unspec
 ;;^UTILITY(U,$J,358.3,923,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,923,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,924,0)
 ;;=B19.10^^6^104^15
